18F-FDG uptake in less affected lung field provides prognostic stratification in patients with interstitial lung disease

Journal of Nuclear Medicine

Volumn 57, Issue 12, 2016, Pages 1899-1904

  Nobashi, Tomomi ^a   Kubo, Takeshi ^a   Nakamoto, Yuji ^a   Handa, Tomohiro ^a   Koyasu, Sho ^a   Ishimori, Takayoshi ^a   Mishima, Michiaki ^a   Togashi, Kaori ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

FDG; Interstitial lung disease; PET CT; Prognosis

Indexed keywords

CARBOHYDRATE ANTIGEN; FLUORODEOXYGLUCOSE F 18; LACTATE DEHYDROGENASE; SURFACTANT PROTEIN D;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK ASSESSMENT; DIAGNOSTIC IMAGING; LUNG; LUNG DISEASES, INTERSTITIAL; METABOLISM; MIDDLE AGED; OBSERVER VARIATION; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; AGED; BIOLOGICAL TRANSPORT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; OBSERVER VARIATION; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 85001022694     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.116.174946     Document Type: Article

References (19)

1. Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156:684-691.
2. Ryerson CJ, Vittinghoff E, Ley B, et al. Predicting survival across chronic interstitial lung disease: The ILD-GAP model. Chest. 2014;145:723-728.
3. Kim ES, Choi SM, Lee J, et al. Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis. Chest. 2015;147:430-437.
4. Raghunath S, Rajagopalan S, Karwoski RA, et al. Quantitative stratification of diffuse parenchymal lung diseases. PLoS One. 2014;9:e93229.
5. Ley B, Elicker BM, Hartman TE, et al. Idiopathic pulmonary fibrosis: CT and risk of death. Radiology. 2014;273:570-579.
6. Ozuno NT, Akamatsu H, Takahashi H, Fujii N, Yoshida S. Quantitative diagnosis of connective tissue disease-associated interstitial pneumonia using thoracic computed tomography images. Clin Rheumatol. 2015;34:2113-2118.
7. Camiciottoli G, Orlandi I, Bartolucci M, et al. Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest. 2007;131:672-681.
8. Courtois A, Nusgens BV, Hustinx R, et al. 18F-FDG uptake assessed by PET/CT in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. J Nucl Med. 2013;54:1740-1747.
9. Nakatsuka Y, Handa T, Nakamoto Y, et al. Total lesion glycolysis as an IgG4-related disease activity marker. Mod Rheumatol. 2015;25:579-584.
10. Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol. 2014;9:157-179.
11. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733-748.
12. Nusair S, Rubinstein R, Freedman NM, et al. Positron emission tomography in interstitial lung disease. Respirology. 2007;12:843-847.
13. Groves AM, Win T, Screaton NJ, et al. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT. J Nucl Med. 2009;50:538-545.
14. Lee EY, Wong CS, Fung SL, Yan PK, Ho JC. SUV as an adjunct in evaluating disease activity in idiopathic pulmonary fibrosis: A pilot study. Nucl Med Commun. 2014;35:631-637.
15. Uehara T, Takeno M, Hama M, et al. Deep-inspiration breath-hold 18F-FDGPET/CT is useful for assessment of connective tissue disease associated interstitial pneumonia. Mod Rheumatol. 2016;26:121-127.
16. Win T, Thomas BA, Lambrou T, et al. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients. Eur J Nucl Med Mol Imaging. 2014;41:337-342.
17. Lambrou T, Groves AM, Erlandsson K, et al. The importance of correction for tissue fraction effects in lung PET: preliminary findings. Eur J Nucl Med Mol Imaging. 2011;38:2238-2246.
18. Fukuda Y, Ferrans VJ, Schoenberger CI, Rennard SI, Crystal RG. Patterns of pulmonary structural remodeling after experimental paraquat toxicity: The morphogenesis of intraalveolar fibrosis. Am J Pathol. 1985;118:452-475.
19. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301-1306.